Archive by Tag: Paul Meade

Predictions for Healthcare in 2012

Industry Insights from Paul Meade, M. Sc., MPH While the Mayans might have been good at developing a cosmic calendar with 27,000-year cycles, I will try to venture only one or two years out and predict some developments within the[...]

Thought Leader Select Announces Key Opinion Leader Assessments in Chronic Pain, Colorectal Surgery, and Gastroenterology

New Press Release from the Offices of Thought Leader Select February 2, 2012 (Chapel Hill, NC) Thought Leader Select is pleased to announce a pair of key opinion leader (KOL) identification and profiling projects to support the development pipeline of[...]

The Sunshine Act: The Good, the Bad, and the Ugly

Industry Insights from Paul Meade, M. Sc, MPH The Sunshine Act is on the horizon, and all we know for certain is that things will be different. Will the changes be good, bad, or ugly for healthcare and the biopharmaceutical[...]

Clinical Trial Ethics

Industry Insights from Paul Meade, M. Sc, MPH According to an article published in the Archives of Internal Medicine, Dr Joseph Ross claimed a study conducted by Parke-Davis, before it was acquired by Pfizer, using gabapentin (Neurontin), as the drug[...]

The Sunshine Act: Who Pays for It Anyway?

Industry Insights from Paul Meade, M.Sc., MPH By now, just about everyone involved in healthcare has heard about the Sunshine Provision (also known as the Sunshine Act). Starting January 1, 2012, any U.S. drug or device manufacturer that provides compensation[...]

Paul Meade Accepts Invitation to Speak at AACE Annual Meeting

March 31, 2011 (CHAPEL HILL, NC)—Paul Meade, the president and founder of Thought Leader Select, a Research Triangle, NC company focused on facilitating medical expert collaborations with the biopharmaceutical and other healthcare industries, has accepted an invitation to speak at[...]

Should Doctors Be Paid By Drug Companies?

Industry Insights from Paul Meade, M.Sc., MPH Should doctors be paid by drug companies? Well, I guess that depends on the reason for the payment. If a physician, known for her expertise in a given area, is asked by a[...]

When Should Politics Stand in the Way of Healthcare?

Paul Meade, M.Sc., MPH Well, there’s an easy answer: NEVER! I could stop there and be content with “enough said,” but I would like to expand on my concerns for a minute. The Obama administration has made some noble attempts[...]

Transparency and the Sunshine Provision – Is This a Good or Bad Thing?

Industry Insights from Paul Meade, M.Sc., MPH The Physician Payment Sunshine Provision is a part of the Patient Protection and Affordable Care Act passed by the U. S. Congress in March of last year. The provision will go into effect[...]

The Sunshine Act and Working with Thought Leaders

Industry Insights from Paul Meade, M.Sc. MPH With the Sunshine Act getting closer to implementation, every company that works with thought leaders is preparing for full disclosure and transparency in the way they work and compensate these physicians and other[...]